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Peptide growth factors and cytokines modulate both normal and impaired wound healing. Topical application of growth
factors in the form of ear drops may counteract impairment of wound healing in the tympanic membrane (TM). We
applied keratinocyte growth factor (KGF), transforming growth factor (TGF)-a or basic  broblast growth factor (bFGF)
to the perforated TMs of rats in which healing impairment had been caused by systemic administration of a
glucocorticoid . Histologic studies of the injured TM, including anti-5-bromo-2Æ-deoxyuridine immunohistochemistry, were
performed on the third day after wounding. In the control ear, epidermal migration was markedly inhibited by
glucocorticoid treatment and no hyperplasia was observed in any layer at the perforation edge. TMs treated with KGF
showed marked hyperplasia in the epithelial layer at the perforation edge. In the bFGF- and TGF-a-treated groups,
hyperplasia was observed in the epithelial and intermediate layers of the TM near the malleus handle and annulus, while
no hyperplasia was seen in any layer at the perforation edge. Only KGF , therefore, improved epidermal migration in the
TM, while all the growth factors tested induced hyperplasia in the TM. Key words : dexamethasone, ear drum,
histopathology, peptide growth factor, wound healing defect.
INTRODUCTION
The tympanic membrane (TM) is a trilaminar struc-
ture composed of an outer layer of strati ed
squamous epithelium, a middle layer of  brous con-
nective tissue and an inner lining of mucosa (1). In
the  rst stage of normal TM healing, epidermal cells
begin to proliferate mainly at the annulus and around
the handle of the malleus. The outer epithelium then
migrates over the perforation. In this way, a marked
accumulation of epidermis occurs at the edge of
perforation and then closes over the defect (2). Epi-
dermal migration appears to be a key factor in the
healing of TM perforations (3).
Wound healing proceeds via a series of coordinated
events mediated by certain cytokines in order to
restore the integrity of tissue (4). Various conditions,
such as immunode ciency, venous stasis, diabetes
mellitus and prolonged administration of anti-in am-
matory steroids, result in delayed wound healing (5,
6). Several studies have indicated that peptide growth
factors and cytokines are key modulators in normal
and impaired wound healing.
We previously presented a model of impaired
wound healing in the TM in glucocorticoid-treated
rats, and examined the regulation of mRNA expres-
sion for keratinocyte growth factor (KGF), trans-
forming growth factor (TGF)-a and basic  broblast
growth factor (bFGF) in the wounded TMs of these
animals using a semi-quantitative reverse transcrip-
tion-polymerase chain reaction (RT-PCR) (7). Induc-
tion of KGF, TGF-a and bFGF mRNA expression
after TM injury was signi cantly reduced in steroid-
treated rats compared to normal controls. As down-
regulation of growth factors is associated with
wound-healing defects in the TM, we hypothesized
that exogenously applied growth factors would re-
verse wound-healing defects in the TMs of glucocorti-
coid-treated rats.
In the present study, we considered hyperplasia in
the epithelial layer at the perforation edge as a histo-
logical indicator of improved healing. We examined
perforated TMs in glucocorticoid-treated rats follow-
ing the direct application of KGF, TGF-a or bFGF
in order to assess differences in the biologic effects of
these growth factors on wound healing in the TM.
MATERIALS AND METHODS
Glucocorticoid treatment
Adult male Wistar rats weighing 230–300 g were
used. All experiments were performed according to
the US National Institutes of Health (NIH) Guide
for the Care and Use of Laboratory Animals. A total
of 21 rats were injected subcutaneously at 09.00 daily
with dexamethasone (DEX; 1 mg:kg body weight)
diluted in phosphate-buffered saline (PBS). Seven
control rats were injected with PBS. Daily injection
of DEX was continued during the wound-healing
period.
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Operative procedure
DEX-treated rats or control rats were anesthetized
intraperitoneally with sodium pentobarbital (0.2 ml:
100 g). On the sixth day of treatment with either
DEX or PBS, 1.5-mm perforations were made under
sterile conditions in the posterior:superior quadrant
of the pars tensa of the TMs of both ears using an
otomicroscope and a 22-gauge needle. Gelfoam
(Pharmacia Upjohn, Kalamazoo, MI) was left in
place at the perforation edge.
Application of growth factors to the TM
Twenty-one DEX-treated rats with bilateral TM per-
forations were divided into 3 groups of 7 rats each
(Groups A, B and C). On Days 0 and 2 after wound-
ing, the right TM of rats in Group A was treated
locally with 0.5 mg of KGF (a gift from Dr J. Rubin)
diluted in 5 ml of PBS. The right TM of rats in Group
B was treated with 0.5 mg of bFGF (Upstate Biotech-
nology, Lake Placid, NY) diluted in 5 ml of PBS,
while the right TM of rats in Group C was treated
with 0.5 mg of TGF-a (Bachem Feinchemikalien AG,
Bubendorf, Switzerland) diluted in 5 ml of PBS. The
left TM of rats in each group was treated with 5 ml of
PBS only. In all animals, Gelfoam was left in place at
the perforation edge as a scaffold material for heal-
ing. The treatment solution was applied directly to
the Gelfoam. Animals that demonstrated signs of
external otitis or otitis media prior to or after appli-
cation of growth factor were excluded from the study.
Histological analysis
On the third day after wounding, all animals were
injected intraperitoneally with 5-bromo-2Æ-de-
oxyuridine (BrdU) (60 mg:kg; Sigma, St. Louis, MO).
Two hours after injection, the animals were deeply
anesthetized with intraperitoneal sodium pentobarbi-
tal and decapitated. The temporal bones were re-
moved and  xed in 10% formalin for 2 weeks. After
 xation the specimens were decalci ed in 10% EDTA
solution for 10 days and then embedded in paraf n
using routine methods. The temporal bones were cut
into serial 5-mm sections in a plane perpendicular to
the malleus handle, from above the short process of
the malleus to below the umbo. Tissue sections taken
every 50 mm were mounted on glass slides. Some
slides were stained with hematoxylin –eosin, while
other sections were processed for immunohistochemi-
cal analysis using monoclonal anti-BrdU antibody
(DAKO, G lostrup, Denmark) to identify mitotic cells
in the regenerating TM.
BrdU immunohistochemical staining
Some sections were deparaf nized with xylene and
rehydrated in a descending ethanol series. After these
sections were washed in PBS and digested with
pepsin:HCl solution, sections were incubated with 3%
hydrogen peroxide for 5 min followed by 10% horse
serum (Vector, Burlingame, CA) for 20 min at room
temperature. After wiping off excess serum, sections
were incubated with anti-BrdU antibody and diluted
1:50 in PBS for 20 min at room temperature. After
washing, sections were incubated with biotinylated
anti-mouse IgG (Vector) diluted 1:200 for 30 min,
and exposed to peroxidase-linked avidin –biotin com-
plex using a Vectastain Elite ABC kit (Vector). To
visualize the incorporated BrdU, the sections were
treated with 3,3-diaminobenzene tetrahydrochloride
(DAB; MBL, Nagoya, Japan) and counterstained
with hematoxylin.
BrdU -immunoreactive cell count
Sections were examined under a light microscope at a
magni cation of ½100 (Olympus, Tokyo, Japan).
Three different sections containing TM perforations
were chosen at random for each ear; in all, 35 sec-
tions from each group were examined for BrdU-
stained cells. BrdU-reactive cells were counted from
one perforation edge to the annulus and from the
opposite perforation edge to the opposite side of the
annulus. The length of the TM was also measured.
We compared mean numbers of labeled cells in a
500-mm length of TM in each group to mean num-
bers of labeled cells in the control ear and in rats
without steroid treatment. The means and SDs of
these values were analyzed using the Mann –Whitney
U-test.
RESULTS
Histopathologic  ndings in perforated TMs of gluco-
corticoid-treated and non-treated rats. In non-gluco-
corticoid-treated rats, conventional histologic
preparations at 3 days indicated that the healing
process following TM perforation had begun. All
three layers of the TM (epithelial layer, intermediate
layer and mucosal layer) were thickened (Fig. 1),
especially the epithelial layer; hyperplasia extended
from near the malleus and annulus to the edge of the
TM perforation, showing proliferation involving four
to  ve cell layers (F ig. 1B). Hyperplasia in the inter-
mediate layer was mainly localized to near the
malleus handle, and did not advance to the edge of
the TM perforation. In the mucosal layer, hyper-
plasia progressed to areas near the edge of the TM
perforation (F ig. 1B).
In glucocorticoid-treated rats, repair following TM
perforation was retarded. Mild hyperplasia of the
epithelial layer was observed near the malleus handle
and adjacent to the annulus, while no hyperplasia
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Fig. 1. Histopathologic  ndings of TM perforation in non-glucocorticoid-treated rats 3 days after wounding (hematoxylin –
eosin staining). (A) Hyperplasia extended from around the malleus and annulus to the edge of the perforation (arrows). (B)
All three layers of the TM were thickened. The epithelial layer extended to the edge of the perforation (asterisk). The
surface of the epithelial layer was keratinized (arrowheads ). EAC¾external auditory canal; M¾malleus; E¾epithelial
layer; Im¾ intermediate layer; mu¾mucosal layer; G¾granulation.
was observed in any layer at the perforation edge
(F ig. 2).
Histopathologic  ndings following TM perforation
and application of KGF
Compared to TMs of glucocorticoid-treated rats that
received local PBS application (control ears), TMs of
glucocorticoid-treated rats that received KGF
showed marked hypertrophy in the epithelial layer at
3 days (Fig. 3A). The epithelial layer proliferated by
two to four cell layers, and corni cation and kera-
tinization of epithelial cells were observed in some
areas (F ig. 3B). While hyperplasia was not observed
in any layer at the perforation edge in the control
group, marked hyperplasia was observed in the ep-
ithelial layer at the perforation edge in the KGF-
treated group (Fig. 3B). No hyperplasia was detected
in the intermediate or mucosal layers. On BrdU
immunohistochemical staining, a few BrdU-positive
cells were found in all layers near the malleus in the
control ear. In the KGF-treated ears, many BrdU-
positive cells were also found along the basement
membrane of the epithelial layer from the malleus to
the edge of TM perforation (Fig. 4). BrdU-positive
cells were also detected in the mucosal layer from the
malleus to the perforation edge, but were almost
absent in the intermediate layer (F ig. 4).
Histopathologi c  ndings following perforation and
application of bFGF
Compared to the control ears, hyperplasia was ob-
served in the epithelial and intermediate layers of the
TM around the malleus handle and annulus in the
bFGF-treated group at 3 days but was nearly absent
in the mucosal layer of the TM (F ig. 5). Migration
was markedly inhibited, and no hyperplasia was ob-
served in any layer at the perforation edge (Fig. 5).
BrdU-staining cells were observed in a single row
along the basement membrane of the epithelial layer,
mainly from the malleus to the perforation edge (F ig.
6). A few BrdU-positive cells were observed in the
intermediate and mucosal layers.
Histopathologi c  ndings following perforation and
direct application of TGF-a
As in the bFGF-treated group, hyperplasia was ob-
served at 3 days in the epithelial and intermediate
Fig. 2. H istopathologic  ndings of TM perforation in glu-
cocorticoid-treated rats 3 days after wounding (hema-
toxylin –eosin staining). Mild hypertrophy of the epithelial
layer was observed around the malleus handle and adjacent
to the annulus, while no hyperplasia was observed in any
layer at the perforation edge (arrows). Small arrowheads
indicate the epithelial layer and large arrowheads indicate
the intermediate layer. For abbreviations, see F ig. 1.
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Fig. 3. H istopathologic  ndings of TM perforation following direct application of KGF in glucocorticoid-treated rats 3
days after wounding (hematoxylin –eosin staining). TMs showed marked hypertrophy in the epithelial layer at the
perforation edge (arrows ). Slight keratinization was observed on the surface of the epithelial layer (arrowhead). For
abbreviations, see F ig. 1.
layers of the TM around the malleus handle and
annulus, while no hyperplasia was found in any layer
at the perforation edge in TGF-a-treated ears (F ig.
7). Hyperplasia of the intermediate layer was ob-
served around the malleus, and was more prominent
than in the KGF- and bFGF-treated groups. BrdU-
stained cells were observed in the epithelial, interme-
diate and mucosal layers (F ig. 8). The presence of
BrdU-positive cells in the intermediate layer was a
characteristic  nding in TGF-a-treated ears.
BrdU-labeled cell count
BrdU-positive cells were counted along a 0.5-mm
length of the TM in sections from non-glucocorti-
coid-treated rats, glucocorticoid-treated rats whose
TMs received PBS (control ears), glucocorticoid-
treated rats whose TMs received KGF (KGF-treated
ears), glucocorticoid-treated rats whose TMs received
bFGF (bFGF-treated ears) and glucocorticoid-
treated rats whose TMs received TGF-a (TGF-a-
treated ears). Three histologic sections were randomly
selected for each ear, and a total of 21 sections for
each group were examined for counting BrdU-posi-
tive cells (F ig. 9). Mean numbers of BrdU-positive
cells in KGF-treated ears, bFGF-treated ears and
TGF-a-treated ears were 15.692.0, 15.891.6 and
18.992.0 respectively, and all these values were sig-
ni cantly higher than those in control ears (pB0.01,
t-test). No statistically signi cant differences in num-
bers of BrdU-positive cells were observed between the
three groups of treated ears.
Fig. 5. Histopathologic  ndings of TM perforation follow-
ing direct application of bFGF in glucocorticoid-treated
rats 3 days after wounding (hematoxylin –eosin staining).
Hyperplasia was observed in the epithelial (small arrow -
heads ) and intermediate (large arrowheads ) layers of the
TM around the malleus handle and annulus, but no hyper-
plasia was observed in any of the layers at the perforation
edge (arrows). For abbreviations, see F ig. 1.
Fig. 4. BrdU-labeled cells in TM perforation following
direct application of KGF in glucocorticoid-treated rats 3
days after wounding. Many BrdU-positive cells were found
along the basement membrane of the epithelial and mu-
cosal layers and from the malleus to the edge of the
perforation (arrows). For abbreviations, see Fig. 1.
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Fig. 6. BrdU-labeled cells in TM perforation following
direct application of bFGF in glucocorticoid-treated rats 3
days after wounding. BrdU-positive cells were observed
aligned in a single row along the basement membrane of
the epithelial layer (arrows ), mainly from the malleus to the
perforation edge. For abbreviations, see F ig. 1.
Fig. 8. BrdU-labeled cells in TM perforation with direct
application of TGF-a in glucocorticoid-treated rats 3 days
after wounding. BrdU-positive cells were observed in the
epithelial, intermediate and mucosal layers (arrows). For
abbreviations, see F ig. 1.
of KGF on TM healing included an important dis-
tinctive feature, namely the promotion of migration.
We used a model of impaired TM healing in
glucocorticoid-treated rats and demonstrated histo-
logically that no epidermal hyperplasia occurred at
the edge of the perforation, although a ridge of
epithelium was seen a small distance away from the
perforation in these rats. These  ndings suggested
that glucocorticoid treatment disrupted wound heal-
ing by arresting epidermal migration. The animal
model presented provides evidence that patients with
prolonged administration of steroids may have an
increased risk of complications as a result of otologic
surgery.
We also examined whether topical application of
KGF, bFGF or TGF-a could reverse wound healing
abnormalities in glucocorticoid-treated rats. We
DISCUSSION
This is the  rst report to indicate that KGF may play
an important role in epidermal migration, which is a
key factor in the healing of TM perforations. In our
previous experiments, we found that KGF and TGF-
a mRNA expression were induced rapidly, peaking 3
days after wounding; this suggested that both growth
factors might be involved in the early stage of TM
repair (8). However, differences in actions between
these two growth factors were not clari ed. We
showed in the present work that the biologic action
Fig. 7. H istopathologic  ndings of TM perforation follow-
ing direct application of TGF-a in glucocorticoid-treated
rats 3 days after wounding (hematoxylin –eosin staining).
Hyperplasia was observed in the epithelial (small arrow -
heads ) and intermediate (large arrowheads) layers of the
TM around the malleus handle and annulus, but no hyper-
plasia was found in any layer at the perforation edge
(arrows). For abbreviations, see F ig. 1.
Fig. 9. Comparison of numbers of BrdU-labeled cells in the
regenerating TMs among KGF-, bFGF-, TGF-a- and PBS-
treated ears in DEX-treated rats. Values represent means9
SDs.
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counted numbers of BrdU-stained cells in the TM in
a KGF-treated group, a TGF-a-treated group and a
bFGF-treated group. Numbers of BrdU-positive
cells signi cantly increased in the TM in all groups
of treated ears compared with the untreated control
ears, but no signi cant difference was observed in
the number of BrdU-positive cells between the three
growth factor-treated groups. These results demon-
strated that KGF, bFGF and TGF-a increased the
mitotic activity of epithelial cells or  brous connec-
tive tissue cells of the TM in glucocorticoid-treated
rats.
An important result of the current study is that
TMs treated with KGF in glucocorticoid-treated rats
showed marked hyperplasia in the epithelial layer at
the perforation edge, while in bFGF-treated and
TGF-a-treated ears hyperplasia was observed in the
epithelial and intermediate layers of the TM around
the malleus handle and annulus but not in any layer
at the perforation edge. These  ndings indicate that
only KGF reversed the steroid-induced arrest in epi-
dermal migration.
Our results suggest that topical use of KGF may
alleviate TM healing disorders involving a loss of
epithelial hyperplasia at the perforation edge. In the
future, it may be possible to therapeutically apply
carefully selected growth factors for the treatment of
healing disorders affecting TM perforations.
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